Thursday, April 01, 2021 9:53:43 AM
It's called momentum. There is a whole class of investors called MOMO players. They see momentum building and they pile in buying increasing the upward momentum when they sense a top they bail out. The 116 million shares day Anavex had is an extreme example of the MOMO players at work. This usually does not create a sustainable increase in the share price.
There are other investors that see a stock start to run up and they feel like they are missing the train so they start chasing the stock to get in as it runs up. FOMO... fear of missing out. These investors tend to become another class of investors called bag holders.
I hope what you are referring to is the situation where the information around a stock turns positive with a solid foundation being put in place for real growth and profits. The value investors see that situation and start buying what they perceive as a mispriced stock causing the share price to move up. That share price movement attracts attention from other investors who look at the DD and see the same potential and buy in continuing to push the share price higher. The increasing share price causes more awareness of the company i.e. more eyeballs. That increased awareness becomes large enough to create media stories which can become an exponential increase in awareness. The positive feedback loop you were referring too kicks in and the Anavex rocket launches.
Just my thoughts on the question you asked.
There are other investors that see a stock start to run up and they feel like they are missing the train so they start chasing the stock to get in as it runs up. FOMO... fear of missing out. These investors tend to become another class of investors called bag holders.
I hope what you are referring to is the situation where the information around a stock turns positive with a solid foundation being put in place for real growth and profits. The value investors see that situation and start buying what they perceive as a mispriced stock causing the share price to move up. That share price movement attracts attention from other investors who look at the DD and see the same potential and buy in continuing to push the share price higher. The increasing share price causes more awareness of the company i.e. more eyeballs. That increased awareness becomes large enough to create media stories which can become an exponential increase in awareness. The positive feedback loop you were referring too kicks in and the Anavex rocket launches.
Just my thoughts on the question you asked.
The American Republic will endure until the day Congress discovers that it can bribe the public with its own money.
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
